University of Plymouth

United Kingdom - Plymouth

Go to:

Specialists in this centre

Professor of Neurology

Plymouth,United Kingdom

Closed for participation

The Lighthouse 2 study is a phase 3 clinical trial in which we will investigate the efficacy of the drug Triumeq.

Archived

Amylyx Pharmaceuticals Inc is conducting a phase 3 trial to determine the safety and efficacy of their compound 'AMX0035'.

If you would like to contact us or register for a trial, leave your details here.